New diabetes clinical trial: A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD

Published on: August 18, 2024 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: GZR101 Injection; Drug: GZR33 Injection; Drug: Insulin aspart
Sponsors: Gan and Lee Pharmaceuticals, USA
Recruiting
https://ift.tt/niOuTEY